Metsera, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Metsera, Inc. 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MTSR
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
CEOChristopher Whitten Bernard
CEOChristopher Whitten Bernard
Employees81
Employees81
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2022
Founded2022
Employees81
Employees81
MTSR Key Statistics
Market cap3.71B
Market cap3.71B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today$36.08
High today$36.08
Low today$34.75
Low today$34.75
Open price$35.53
Open price$35.53
Volume1.05M
Volume1.05M
52 Week high$47.40
52 Week high$47.40
52 Week low$12.30
52 Week low$12.30
People also own
Based on the portfolios of people who own MTSR. This list is generated using Robinhood data, and it’s not a recommendation.